Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Relation of FGFR2 genetic polymorphisms to the association between oral contraceptive use and the risk of breast cancer in Chinese women.

American journal of epidemiology - 15 Apr 2011

Xu Wang-Hong, Shu Xiao-Ou, Long Jirong, Lu Wei, Cai Qiuyin, Zheng Ying, Xiang Yong-Bing, Dai Qi, Zhao Gen-Ming, Gu Kai, Bao Ping-Ping, Gao Yu-Tang, Zheng Wei

Abstract excerpt

The fibroblast growth factor receptor 2 gene (FGFR2) has been associated with the risk of breast cancer in multiple ethnic populations, and its effect has been suggested to be hormone-dependent. A large, 2-stage, population-based case-control study was conducted in urban Shanghai, China, during the periods of 1996-1998 and 2002-2005. Exposure and genotyping information from 2,073 patients with breast cancer and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Asian People
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Contraceptives, Oral, Hormonal

Share to Disease Susceptibility

Share to Estrogen Replacement Therapy

Share to Receptor, Fibroblast Growth Factor, Type 2

Share to Risk Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 21382839
DOI: 10.1093/aje/kwq460
PMCID: PMC3071853

Genes

FGFR2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Relation of FGFR2 genetic polymorphisms to the association between oral contraceptive use and the risk of breast cancer in Chinese women.PMID 21382839Read ↗

Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women.Semantic proximity Read ↗

Variants of FGFR2 and their associations with breast cancer risk: a HUGE systematic review and meta-analysis.Semantic proximity Read ↗

Assessing interactions between the associations of fibroblast growth factor receptor 2 common genetic variants and hormone receptor status with breast cancer risk.Semantic proximity Read ↗

Current evidence on the relationship between three polymorphisms in the FGFR2 gene and breast cancer risk: a meta-analysis.Semantic proximity Read ↗

FGFR2 intronic polymorphisms interact with reproductive risk factors of breast cancer: results of a case control study in Japan.Semantic proximity Read ↗

The FGFR2 Variant rs13387042 is Associated With Breast Cancer Risk: A Meta-Analysis and Systematic Review.Semantic proximity Read ↗

FGFR2 intronic SNPs and breast cancer risk: associations with tumor characteristics and interactions with exogenous exposures and other known breast cancer risk factors.Semantic proximity Read ↗

A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer.Semantic proximity Read ↗

Association between fibroblast growth factor receptor-2 gene polymorphism and risk of breast cancer in Chinese populations: A HuGE review and meta-analysis.Semantic proximity Read ↗

Genetic variants of fibroblast growth factor receptor 2 (FGFR2) are associated with breast cancer risk in Chinese women of the Han nationality.Semantic proximity Read ↗

Three novel functional polymorphisms in the promoter of FGFR2 gene and breast cancer risk: a HuGE review and meta-analysis.Semantic proximity Read ↗

Associations of polymorphisms in the genes of FGFR2, FGF1, and RBFOX2 with breast cancer risk by estrogen/progesterone receptor status.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.